Article Details

Resurgeant Veklury delivers Gilead $1.9 billion in sales and an earnings surprise | FiercePharma

Retrieved on: 2021-10-29 16:22:40

Tags for this article:

Click the tags to see associated articles and topics

Resurgeant Veklury delivers Gilead $1.9 billion in sales and an earnings surprise | FiercePharma. View article details on HISWAI: https://www.fiercepharma.com/pharma/resurgeant-veklury-delivers-gilead-1-9-billion-sales-and-earnings-surprise

Excerpt

With sales of its HIV drugs still slow to rebound from the pandemic, Gilead got a welcome surprise from the performance of Veklury (remdesivir), ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up